Goldstein v. Beliv, LLC.

CourtDistrict Court, S.D. Florida
DecidedOctober 28, 2022
Docket9:22-cv-80643
StatusUnknown

This text of Goldstein v. Beliv, LLC. (Goldstein v. Beliv, LLC.) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Goldstein v. Beliv, LLC., (S.D. Fla. 2022).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA

CASE NO. 22-CV-80643-RAR

JASON GOLDSTEIN, individually and on behalf of all others similarly situated,

Plaintiff,

v.

BELIV, LLC,

Defendant. _____________________________________/

ORDER GRANTING DEFENDANT’S MOTION TO STAY

THIS CAUSE comes before the Court upon Defendant’s Motion to Stay, [ECF No. 8] (“Motion”), filed on July 15, 2022. On July 29, 2022, Plaintiff filed his Response in Opposition, [ECF No. 10], and on August 5, 2022, Defendant filed a Reply, [ECF No. 11].1 Defendant asks this Court to stay all proceedings in this matter pending the resolution of the case, Kelly v. Beliv LLC, No. 1:21-cv-08134-LJL (S.D.N.Y. filed Oct. 1, 2021), in the Southern District of New York (“New York action”). See Mot. 1–2. Having carefully reviewed the record, the parties’ briefing, and being otherwise fully advised, the Court hereby GRANTS Defendant’s Motion. BACKGROUND This action was filed on April 26, 2022. See Compl. [ECF No. 1]. Plaintiff alleges that Defendant improperly claims its Nectar Petit Fruit Punch contains “no preservatives”—even though the ingredient label states the fruit punch contains ascorbic and citric acid. Id. at ¶¶ 1–3.

1 Defendant also filed a Motion to Dismiss, [ECF No. 17], on September 12, 2022. On August 26, 2022, Plaintiff filed a Response in Opposition to the Motion to Dismiss, [ECF No. 18], and Defendant filed a Reply, [ECF No. 19], on October 3, 2022. Specifically, Plaintiff avers ascorbic and citric acid are preservatives and function as preservatives in the fruit punch. Id. ¶ 3. Counsel for Plaintiff previously filed a similar suit in the Southern District of New York on October 21, 2021. See Kelly v. Kasim Int. Corp., No. 1:21-cv-08134-LJL (S.D.N.Y. 2021).

The plaintiff in the New York action alleged that Kasim International Corporation improperly claimed that their Nectar Petit Mango beverage contained no preservatives, despite the presence of ascorbic and citric acid. See Mot. Ex. 2 [ECF No. 8-2] ¶ 6. On December 1, 2021, plaintiff Kelly filed a First Amended Complaint in the New York action substituting Beliv LLC for Kasim International Corporation. See Mot. Ex. 3 [ECF No. 8-3] at 2. The Amended Complaint alleged that the packaging of Beliv’s mango beverage stated that the drink contained no preservatives, even though the beverage contained ascorbic and citric acid. See Mot. Ex. 2. ¶¶ 6, 21. The plaintiff in the New York action further maintained that ascorbic and citric acid are preservatives and function as preservatives in the beverage. See id. ¶¶ 21–22, 24. Defendant urges the Court in its Motion to stay this later-filed action under the first-to-file

rule until the New York action is fully adjudicated. See Mot. at 2. LEGAL STANDARD Where two federal actions involve overlapping issues and parties, “there is a strong presumption across the federal circuits that favors the forum of the first-filed suit under the first- filed rule.” Manuel v. Convergys Corp., 430 F.3d 1132, 1135 (11th Cir. 2005). This first-to-file rule “is a doctrine of federal comity, intended to avoid conflicting decisions and promote judicial efficiency . . . .” Yao v. Ulta Beauty, Inc., No. 18-22213, 2018 WL 4208324, at *1 (S.D. Fla. Aug. 8, 2018) (citations omitted). The purpose of the rule “is to avoid the waste of duplication, to avoid rulings which may trench upon the authority of sister courts, and to avoid piecemeal resolution of issues that call for a uniform result.” Peterson v. Aaron’s, Inc., No. 1:14-CV-1919-TWT, 2015 WL 224750, at *1 (N.D. Ga. Jan. 15, 2015) (quoting Cadle Co. v. Whataburger of Alice, Inc., 174 F.3d 599, 603 (5th Cir.1999)) (internal quotation marks omitted). To determine whether the first-to-file rule applies, courts consider “(1) the chronology of

the two actions, (2) the similarity of the parties, and (3) the similarity of the issues.” Women’s Choice Pharms., LLC v. Rook Pharms., Inc., No. 16-62074, 2016 WL 6600438, at *2 (S.D. Fla. Nov. 8, 2016) (citing Laskaris v. Fifth Third Bank, 962 F. Supp. 2d 1297, 1299 (S.D. Fla. 2013)). Neither the parties nor the issues need be identical. See Kelly v. Gerber Prod. Co., No. 21-60602, 2021 WL 2410158, at *1 (S.D. Fla. June 11, 2021). Rather, the parties and the issues “must simply overlap.” Daugherty v. Adams, No. 1:16-CV-02480-LMM, 2017 WL 5484699, at *12 (N.D. Ga. Mar. 22, 2017). Courts have substantial discretion as to the procedural mechanism they can use to address the later-filed case when the first-to-file doctrine applies. See Strother v. Hylas Yachts, Inc., No. 12-80283, 2012 WL 4531357, at *1 (S.D. Fla. Oct. 1, 2012) (internal citations omitted). A district

court may “stay, transfer, or dismiss a duplicative later-filed action.” ASS Armor, LLC v. Under Armour, Inc., No. 15-20853, 2015 WL 2155724, at *2 (S.D. Fla. May 7, 2015). Moreover, “[d]istrict courts have the inherent power to stay litigation pending the outcome of a related proceeding in another forum.” Id. ANALYSIS The first-to-file rule factors apply in this instance and favor the Court staying this action pending the outcome of the New York action. First, the parties do not dispute that the New York action was filed earlier. This action was filed in the Southern District of Florida in April 2022. See generally Compl. The New York action was initially filed in October 2021, see generally Kelly v. Kasim Int. Corp., No. 1:21-cv-08134-LJL, Compl., filed Oct. 1, 2021 (S.D.N.Y. 2021), and the plaintiff in the New York action substituted Beliv in for the original defendant in December 2021, see Mot., Ex. 3 at 3. Therefore, the first factor favors this Court’s deference to the New York action.

Second, the parties are substantially similar. In both actions, the Defendant is Beliv, LLC. Plaintiff in this action argues that the first-to-file rule should not apply because different named plaintiffs representing different putative classes of plaintiffs bring the respective suits. See Resp. at 4. The present case purports to represent plaintiff classes in Florida, Georgia, Alabama, Arkansas, and South Carolina, whereas the New York action purports to represent plaintiff classes in New York, Massachusetts, and Connecticut. See id. However, the dissimilar plaintiff classes do not defeat application of the first-to-file rule. The parties do not have to be identical for the first-to-file rule to apply. The first-to-file rule applies where “some of the parties in one matter are also in the other matter, regardless of whether there are additional unmatched parties in one or both matters.” Cadenasso v. Metro. Life Ins. Co., No. 13-CV-05491-JST, 2014 WL 1510853, at *10

(N.D. Cal. Apr. 15, 2014) (internal citations omitted). In Cadenasso, the court found that the first- to-file rule applied, even though the two cases in question involved different plaintiff classes. Id. The court determined that given the other factors weighing in favor of the first-to-file rule, the mutually exclusive class of plaintiffs was not dispositive. See id.; see also Abreu v. Pfizer, Inc., No. 21-62122, 2022 WL 481184, at *6 (S.D. Fla. Feb. 16, 2022), reconsideration denied, No. 21- 62122, 2022 WL 3370932 (S.D. Fla. Aug. 16, 2022) (“[A]lthough Harris and Abreu are two separate individuals [as plaintiffs], each alleges similar claims against Pfizer and purport to represent a class and subclass of plaintiffs.”). Considering the similarity of the issues in the cases at hand, the parties are substantially similar enough for the first-to-file rule to apply.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Goldstein v. Beliv, LLC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/goldstein-v-beliv-llc-flsd-2022.